South Korea Personalized Medicine Market Size, Share, and COVID-19 Impact Analysis, By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness), By Application (Oncology, CNS, Immunology, Respiratory, and Others), and South Korea Personalized Medicine Market Insights, Industry Trend, Forecasts to 2035

South Korea Personalized Medicine Market Insights Forecasts to 2035

• The South Korea Personalized Medicine Market Size was Estimated at USD 14.8 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 8.44% from 2025 to 2035
• The South Korea Personalized Medicine Market Size is Expected to Reach USD 36.1 Billion by 2035

According to a Research Report Published by Spherical Insights & Consulting, the South Korea Personalized Medicine Market Size is Anticipated to Reach USD 36.1 Billion by 2035, Growing at a CAGR of 8.44% from 2025 to 2035. Increasing as a result of growing awareness of genetic profiling and the growing need for customized treatments brought on by developments in genomic technologies. Market growth is further accelerated by government support for biopharmaceutical innovation and the incorporation of AI and big data analytics into healthcare systems.

Market Overview

The South Korea personalized medicine market refers to the healthcare industry in South Korea that focuses on providing individualized medical treatments based on a person's genetic composition, lifestyle, and surroundings is known as the personalized medicine market. Application, the South Korean personalized medicine market is expanding due to the quick development of genomic technologies, especially in the areas of genetic sequencing and bioinformatics. Whole-genome sequencing has become much more affordable in recent years, making genetic testing more widely available. Furthermore, the South Korean personalized medicine market is growing as a result of patients' growing awareness of and desire for customized medical care. The advantages of personalized medicine are emphasized in educational campaigns run by patient advocacy organizations and healthcare providers, which raises demand for customized treatment regimens.

Report Coverage

This research report categorizes the market for the South Korea personalized medicine market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea personalized medicine market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea personalized medicine market.

Driving Factors

The market for personalized medicine in South Korea is being driven by the rising incidence of chronic illnesses, improvements in genomic technologies, and increased awareness of customized treatments. The need for precision healthcare solutions in hospitals and research facilities is being further accelerated by government programs that support biopharmaceutical innovation, integrate AI and big data analytics, and increase the use of genetic testing in clinical settings.

Restraining Factors

The market for personalized medicine in South Korea is constrained by the high expense of genetic testing, lax reimbursement regulations, and data privacy issues. Widespread adoption is further hampered, particularly in smaller healthcare facilities, by regulatory complexity, a lack of qualified personnel, and the gradual integration of genomic tools into standard care.

Market Segmentation

The South Korea personalized medicine market share is classified into product and application.

• The personalized medicine therapeutics segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea personalized medicine market is segmented by product into personalized medicine diagnostics, personalized medicine therapeutics, personalized medical care, personalized nutrition and wellness. Among these, the personalized medicine therapeutics segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Customized Medicine Therapeutics is a key market segment that experiences significant investment and innovation because it focuses on creating therapies that are customized to each patient's unique profile, which not only increases efficacy but also reduces side effects.

• The oncology segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea personalized medicine market is segmented by application into oncology, CNS, immunology, respiratory, and others. Among these, the oncology segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. In this market, oncology is essential because of the increasing prevalence of cancer, which calls for specifically tailored treatments that increase treatment effectiveness and reduce side effects.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea personalized medicine market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• MyGenomeBox
• GENECAST
• Idience
• Promedius Inc.
• JNPMEDI Inc.
• Mediwhale
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea Personalized Medicine Market based on the below-mentioned segments:

South Korea Personalized Medicine Market, By Product

• Personalized Medicine Diagnostics
• Personalized Medicine Therapeutics
• Personalized Medical Care
• Personalized Nutrition and Wellness

South Korea Personalized Medicine Market, By Application

• Oncology
• CNS
• Immunology
• Respiratory
• Others